Literature DB >> 6770026

Immune response genes control T killer cell response against Moloney tumor antigen cytolysis regulating reactions against the best available H-2 + viral antigen association.

E Gomard, Y Hénin, M J Colombani, J P Lévy.   

Abstract

Cytolytic T lymphocytes (CTL) specific for the virus-induced and leukemia-associated Friend, Moloney, Rauscher (FMR) antigen are easily detected in the spleens of primary and secondary stimulated H-2b or H-2d mice. They react, respectively, with H-2Db + FMR and H-2Kd + FMR; Dd and Kb never being involved. On the other hand, recombinant (KbDd) mice are relatively low responders that produce CTL only after secondary stimulation. Competition and blocking experiments with monospecific anti-H-2 antibodies have demonstrated that on the same H-2b tumor cells, C57BL/6 (H-2b) lymphocytes recognize Db + FMR, whereas B10.A(5R) lymphocytes recognize Kb + FMR, the restriction cannot, therefore be explained by a specific association of viral molecules with certain H-2 products. The CTL response of (B10 X 5R)F1 hybrids is (a) easily detected in primary reaction, the high responder anti-FMR phenotype being dominant and (b) directed against Db + FMR, F1 mice being low responder against Kb + FMR like the B10 parent. These results suggest that a D region-associated immune response gene controls the cell-mediated anti-FMR reaction, the best available H-2 + FMR antigenic association being chosen by CTL precursors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6770026      PMCID: PMC2185873          DOI: 10.1084/jem.151.6.1468

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  H-2 region product as determinant in immune cytolysis of syngeneic tumour cells by anti-MSV T lymphocytes.

Authors:  E Gomard; V Duprez; Y Henin; J P Levy
Journal:  Nature       Date:  1976-04-22       Impact factor: 49.962

Review 2.  Studies of structure and immunosuppression of cross-reactive idiotype in strain A mice.

Authors:  A Nisonoff; S T Ju; F L Owen
Journal:  Immunol Rev       Date:  1977       Impact factor: 12.988

3.  Selective incorporation of H-2 antigenic determinants into Friend virus particles.

Authors:  J E Bubbers; F Lilly
Journal:  Nature       Date:  1977-03-31       Impact factor: 49.962

4.  Evidence for an H-2/viral protein complex on the cell surface as the basis for the H-2 restriction of cytotoxicity.

Authors:  K J Blank; F Lilly
Journal:  Nature       Date:  1977-10-27       Impact factor: 49.962

Review 5.  Responsiveness to HY antigen Ir gene complementation and target cell specificity.

Authors:  E Simpson; R D Gordon
Journal:  Immunol Rev       Date:  1977       Impact factor: 12.988

Review 6.  Immunological suppression of idiotypic specificities.

Authors:  A Nisonoff; S A Bangasser
Journal:  Transplant Rev       Date:  1975

7.  H-2 effects on cell-cell interactions in the response to single non-H-2 alloantigens. II. H-2D region control of H-7.1-specific stimulator function in mixed lymphocyte culture and susceptibility to lysis by H-7.1-specific cytotoxic cells.

Authors:  P J Wettstein; J A Frelinger
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

8.  Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor.

Authors:  R N Germain; M E Dorf; B Benacerraf
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

9.  Secondary antibody responses in vitro to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) by (responder X nonresponder)F1 spleen cells stimulated by parental GAT-macrophages.

Authors:  C W Pierce; R N Germain; J A Kapp; B Benacerraf
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

10.  Exclusive involvement of H-2Db or H-2Kd product in the interaction between T-killer lymphocytes and syngeneic H-2b or H-2d viral lymphomas.

Authors:  E Gomard; V Duprez; T Reme; M J Colombani; J P Levy
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

View more
  15 in total

1.  Susceptibility to a mouse acquired immunodeficiency syndrome is influenced by the H-2.

Authors:  D Hamelin-Bourassa; E Skamene; F Gervais
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

2.  Evidence for H-2-linked control of retrovirus production in Friend virus-induced tumor cell lines.

Authors:  J H Wolfe; K J Blank
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

Review 3.  Role of the major histocompatibility complex in resistance to viral leukemia; its effect on the preleukemic stage of leukemogenesis.

Authors:  P Lonai; E Katz; N Haran-Ghera
Journal:  Springer Semin Immunopathol       Date:  1982

4.  HLA-B27, a dominant restricting element in antiviral responses?

Authors:  E Gomard; M Sitbon; A Toubert; B Bègue; J P Lévy
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

5.  Cytolytic T lymphocyte response to Moloney sarcoma virus.

Authors:  V Duprez; S J Burakoff
Journal:  Surv Immunol Res       Date:  1983

6.  Analysis of haplotype preference in the cytotoxic T-cell response to H-Y.

Authors:  M Brenan; E Simpson; A Müllbacher
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

7.  Multiplicity of virus-encoded helper T-cell epitopes expressed on FBL-3 tumor cells.

Authors:  M Iwashiro; T Kondo; T Shimizu; H Yamagishi; K Takahashi; Y Matsubayashi; T Masuda; A Otaka; N Fujii; A Ishimoto
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Genetic control of CTL responses to AKR/Gross virus: effect of inheritance of Akv proviruses.

Authors:  W R Green; R F Rich
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

9.  H-2D (Rfv-1) gene influence on recovery from Friend virus leukemia is mediated by nonleukemic cells of the spleen and bone marrow.

Authors:  W J Britt; B Chesebro
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

10.  Thymus dictates major histocompatibility complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cells.

Authors:  W M Kast; L P de Waal; C J Melief
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.